Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders [Phase 4]

View source ↗

Summary

This clinical trial update reports on a Phase 4 study of escitalopram in adolescents with major depressive disorder or anxiety disorders, with the current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: Erzurum Regional Training & Research Hospital | Conditions: Major Depressive Disorder, Anxiety Disorders | Phase 4 | Status: UNKNOWN